Physiotherapy, Medicine and Biomedical Sciences
Department
Duke Clinical Research Institute
Durham, Estados UnidosPublications in collaboration with researchers from Duke Clinical Research Institute (2)
2022
-
Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial
JAMA Cardiology, Vol. 7, Núm. 1, pp. 26-34
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116